Treatment of subclinical hypothyroidism reverses ischemia and prevents myocyte loss and progressive LV dysfunction in hamsters with dilated cardiomyopathy

1 Cardiovascular Research Institute-South Dakota Health Research Foundation, University of South Dakota School of Medicine and Sioux Valley Hospitals and Health Systems, and 2 Department of Internal Medicine, University of South Dakota School of Medicine, Sioux Falls, South Dakota Submitted 11 May 2...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of physiology. Heart and circulatory physiology 2005-12, Vol.289 (6), p.H2409-H2415
Hauptverfasser: Khalife, Wissam I, Tang, Yi-Da, Kuzman, James A, Thomas, Tracy A, Anderson, Brent E, Said, Suleman, Tille, Patricia, Schlenker, Evelyn H, Gerdes, A. Martin
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page H2415
container_issue 6
container_start_page H2409
container_title American journal of physiology. Heart and circulatory physiology
container_volume 289
creator Khalife, Wissam I
Tang, Yi-Da
Kuzman, James A
Thomas, Tracy A
Anderson, Brent E
Said, Suleman
Tille, Patricia
Schlenker, Evelyn H
Gerdes, A. Martin
description 1 Cardiovascular Research Institute-South Dakota Health Research Foundation, University of South Dakota School of Medicine and Sioux Valley Hospitals and Health Systems, and 2 Department of Internal Medicine, University of South Dakota School of Medicine, Sioux Falls, South Dakota Submitted 11 May 2005 ; accepted in final form 13 July 2005 Growing evidence suggests that thyroid dysfunction may contribute to progression of cardiac disease to heart failure. We investigated the effects of a therapeutic dose of thyroid hormones (TH) on cardiomyopathic (CM) hamsters from 4 to 6 mo of age. CM hamsters had subclinical hypothyroidism (normal thyroxine, elevated TSH). Left ventricular (LV) function was determined by echocardiography and hemodynamics. Whole tissue pathology and isolated myocyte size and number were assessed. TH treatment prevented the decline in heart rate and rate of LV pressure increase and improved LV ejection fraction. The percentage of fibrosis/necrosis in untreated 4-mo-old CM (4CM; 15.5 ± 2.2%) and 6-mo-old CM (6CM; 21.5 ± 2.4%) hamsters was pronounced and was reversed in treated CM (TCM; 11.9 ± 0.9%) hamsters. Total ventricular myocyte number was the same between 4- and 6-mo-old controls but was reduced by 30% in 4CM and 43% in 6CM hamsters. TH treatment completely prevented further loss of myocytes in TCM hamsters. Compared with age-matched controls, resting and maximum coronary blood flow was impaired in 4CM and 6CM hamsters. Blood flow was completely normalized by TH treatment. We conclude that TH treatment of CM hamsters with subclinical hypothyroidism normalized impaired coronary blood flow, which prevented the decline in LV function and loss of myocytes. thyroid hormones; remodeling; fibrosis; blood flow Address for reprint requests and other correspondence: A. M. Gerdes, Univ. of South Dakota School of Medicine, Cardiovascular Research Inst., 1100 E. 21st St., Sioux Falls, SD 57105 (e-mail: mgerdes{at}usd.edu )
doi_str_mv 10.1152/ajpheart.00483.2005
format Article
fullrecord <record><control><sourceid>proquest_highw</sourceid><recordid>TN_cdi_proquest_miscellaneous_68801568</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68801568</sourcerecordid><originalsourceid>FETCH-LOGICAL-c395t-9e7e32cdfb661e5f78bc108bba6d0b65c4f9f3b4c763fa88e3b24a9a602733f23</originalsourceid><addsrcrecordid>eNp1UcFu1DAQtRAVXQpfgIR84patHSfeRJxQRSnSSly2vVqOPd64cuJgO23zK3wtXnYpXHoaaea9N_PmIfSBkjWldXkp76ceZEhrQqqGrUtC6ldolSdlQWvWvkYrwjgrOGX1OXob4z3JiA1nb9A55aSsat6s0K9dAJkGGBP2Bse5U86OVkmH-2XyqV-Ct9rGAQd4gBAhYhtVD4OVWI4aT4f2mCIeFq-WBNj5GE8Tvw8Qo30AvL3DeolmHlWyfsR2xL0cYsp6-NGmHmvrZAKNlQza-iw1ybz5HToz0kV4f6oX6Pb66-7qptj--Pb96su2UKytU9HCBliptOk4p1CbTdMpSpquk1yTjteqMq1hXaWydSObBlhXVrKV-QUbxkzJLtCno24--ecMMYkhewTn5Ah-joI3DaH5WRnIjkAVsssARkzBDjIsghJxiET8jUT8iUQcIsmsjyf5uRtA_-OcMsiAz0dAb_f9ow0gpn6J1ju_X8T17NwOntKzdNm0goubsiKtmLTJ7MuX2c_3_MdivwElnrY1</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68801568</pqid></control><display><type>article</type><title>Treatment of subclinical hypothyroidism reverses ischemia and prevents myocyte loss and progressive LV dysfunction in hamsters with dilated cardiomyopathy</title><source>MEDLINE</source><source>American Physiological Society</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Khalife, Wissam I ; Tang, Yi-Da ; Kuzman, James A ; Thomas, Tracy A ; Anderson, Brent E ; Said, Suleman ; Tille, Patricia ; Schlenker, Evelyn H ; Gerdes, A. Martin</creator><creatorcontrib>Khalife, Wissam I ; Tang, Yi-Da ; Kuzman, James A ; Thomas, Tracy A ; Anderson, Brent E ; Said, Suleman ; Tille, Patricia ; Schlenker, Evelyn H ; Gerdes, A. Martin</creatorcontrib><description>1 Cardiovascular Research Institute-South Dakota Health Research Foundation, University of South Dakota School of Medicine and Sioux Valley Hospitals and Health Systems, and 2 Department of Internal Medicine, University of South Dakota School of Medicine, Sioux Falls, South Dakota Submitted 11 May 2005 ; accepted in final form 13 July 2005 Growing evidence suggests that thyroid dysfunction may contribute to progression of cardiac disease to heart failure. We investigated the effects of a therapeutic dose of thyroid hormones (TH) on cardiomyopathic (CM) hamsters from 4 to 6 mo of age. CM hamsters had subclinical hypothyroidism (normal thyroxine, elevated TSH). Left ventricular (LV) function was determined by echocardiography and hemodynamics. Whole tissue pathology and isolated myocyte size and number were assessed. TH treatment prevented the decline in heart rate and rate of LV pressure increase and improved LV ejection fraction. The percentage of fibrosis/necrosis in untreated 4-mo-old CM (4CM; 15.5 ± 2.2%) and 6-mo-old CM (6CM; 21.5 ± 2.4%) hamsters was pronounced and was reversed in treated CM (TCM; 11.9 ± 0.9%) hamsters. Total ventricular myocyte number was the same between 4- and 6-mo-old controls but was reduced by 30% in 4CM and 43% in 6CM hamsters. TH treatment completely prevented further loss of myocytes in TCM hamsters. Compared with age-matched controls, resting and maximum coronary blood flow was impaired in 4CM and 6CM hamsters. Blood flow was completely normalized by TH treatment. We conclude that TH treatment of CM hamsters with subclinical hypothyroidism normalized impaired coronary blood flow, which prevented the decline in LV function and loss of myocytes. thyroid hormones; remodeling; fibrosis; blood flow Address for reprint requests and other correspondence: A. M. Gerdes, Univ. of South Dakota School of Medicine, Cardiovascular Research Inst., 1100 E. 21st St., Sioux Falls, SD 57105 (e-mail: mgerdes{at}usd.edu )</description><identifier>ISSN: 0363-6135</identifier><identifier>EISSN: 1522-1539</identifier><identifier>DOI: 10.1152/ajpheart.00483.2005</identifier><identifier>PMID: 16024568</identifier><language>eng</language><publisher>United States</publisher><subject>Animals ; Cardiomyopathy, Dilated - complications ; Cells, Cultured ; Cricetinae ; Disease Progression ; Hypothyroidism - drug therapy ; Hypothyroidism - etiology ; Mesocricetus ; Muscle Cells - drug effects ; Muscle Cells - pathology ; Thyroid Hormones - therapeutic use ; Treatment Outcome ; Ventricular Dysfunction, Left - etiology ; Ventricular Dysfunction, Left - prevention &amp; control</subject><ispartof>American journal of physiology. Heart and circulatory physiology, 2005-12, Vol.289 (6), p.H2409-H2415</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c395t-9e7e32cdfb661e5f78bc108bba6d0b65c4f9f3b4c763fa88e3b24a9a602733f23</citedby><cites>FETCH-LOGICAL-c395t-9e7e32cdfb661e5f78bc108bba6d0b65c4f9f3b4c763fa88e3b24a9a602733f23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,782,786,3043,27933,27934</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16024568$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Khalife, Wissam I</creatorcontrib><creatorcontrib>Tang, Yi-Da</creatorcontrib><creatorcontrib>Kuzman, James A</creatorcontrib><creatorcontrib>Thomas, Tracy A</creatorcontrib><creatorcontrib>Anderson, Brent E</creatorcontrib><creatorcontrib>Said, Suleman</creatorcontrib><creatorcontrib>Tille, Patricia</creatorcontrib><creatorcontrib>Schlenker, Evelyn H</creatorcontrib><creatorcontrib>Gerdes, A. Martin</creatorcontrib><title>Treatment of subclinical hypothyroidism reverses ischemia and prevents myocyte loss and progressive LV dysfunction in hamsters with dilated cardiomyopathy</title><title>American journal of physiology. Heart and circulatory physiology</title><addtitle>Am J Physiol Heart Circ Physiol</addtitle><description>1 Cardiovascular Research Institute-South Dakota Health Research Foundation, University of South Dakota School of Medicine and Sioux Valley Hospitals and Health Systems, and 2 Department of Internal Medicine, University of South Dakota School of Medicine, Sioux Falls, South Dakota Submitted 11 May 2005 ; accepted in final form 13 July 2005 Growing evidence suggests that thyroid dysfunction may contribute to progression of cardiac disease to heart failure. We investigated the effects of a therapeutic dose of thyroid hormones (TH) on cardiomyopathic (CM) hamsters from 4 to 6 mo of age. CM hamsters had subclinical hypothyroidism (normal thyroxine, elevated TSH). Left ventricular (LV) function was determined by echocardiography and hemodynamics. Whole tissue pathology and isolated myocyte size and number were assessed. TH treatment prevented the decline in heart rate and rate of LV pressure increase and improved LV ejection fraction. The percentage of fibrosis/necrosis in untreated 4-mo-old CM (4CM; 15.5 ± 2.2%) and 6-mo-old CM (6CM; 21.5 ± 2.4%) hamsters was pronounced and was reversed in treated CM (TCM; 11.9 ± 0.9%) hamsters. Total ventricular myocyte number was the same between 4- and 6-mo-old controls but was reduced by 30% in 4CM and 43% in 6CM hamsters. TH treatment completely prevented further loss of myocytes in TCM hamsters. Compared with age-matched controls, resting and maximum coronary blood flow was impaired in 4CM and 6CM hamsters. Blood flow was completely normalized by TH treatment. We conclude that TH treatment of CM hamsters with subclinical hypothyroidism normalized impaired coronary blood flow, which prevented the decline in LV function and loss of myocytes. thyroid hormones; remodeling; fibrosis; blood flow Address for reprint requests and other correspondence: A. M. Gerdes, Univ. of South Dakota School of Medicine, Cardiovascular Research Inst., 1100 E. 21st St., Sioux Falls, SD 57105 (e-mail: mgerdes{at}usd.edu )</description><subject>Animals</subject><subject>Cardiomyopathy, Dilated - complications</subject><subject>Cells, Cultured</subject><subject>Cricetinae</subject><subject>Disease Progression</subject><subject>Hypothyroidism - drug therapy</subject><subject>Hypothyroidism - etiology</subject><subject>Mesocricetus</subject><subject>Muscle Cells - drug effects</subject><subject>Muscle Cells - pathology</subject><subject>Thyroid Hormones - therapeutic use</subject><subject>Treatment Outcome</subject><subject>Ventricular Dysfunction, Left - etiology</subject><subject>Ventricular Dysfunction, Left - prevention &amp; control</subject><issn>0363-6135</issn><issn>1522-1539</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1UcFu1DAQtRAVXQpfgIR84patHSfeRJxQRSnSSly2vVqOPd64cuJgO23zK3wtXnYpXHoaaea9N_PmIfSBkjWldXkp76ceZEhrQqqGrUtC6ldolSdlQWvWvkYrwjgrOGX1OXob4z3JiA1nb9A55aSsat6s0K9dAJkGGBP2Bse5U86OVkmH-2XyqV-Ct9rGAQd4gBAhYhtVD4OVWI4aT4f2mCIeFq-WBNj5GE8Tvw8Qo30AvL3DeolmHlWyfsR2xL0cYsp6-NGmHmvrZAKNlQza-iw1ybz5HToz0kV4f6oX6Pb66-7qptj--Pb96su2UKytU9HCBliptOk4p1CbTdMpSpquk1yTjteqMq1hXaWydSObBlhXVrKV-QUbxkzJLtCno24--ecMMYkhewTn5Ah-joI3DaH5WRnIjkAVsssARkzBDjIsghJxiET8jUT8iUQcIsmsjyf5uRtA_-OcMsiAz0dAb_f9ow0gpn6J1ju_X8T17NwOntKzdNm0goubsiKtmLTJ7MuX2c_3_MdivwElnrY1</recordid><startdate>20051201</startdate><enddate>20051201</enddate><creator>Khalife, Wissam I</creator><creator>Tang, Yi-Da</creator><creator>Kuzman, James A</creator><creator>Thomas, Tracy A</creator><creator>Anderson, Brent E</creator><creator>Said, Suleman</creator><creator>Tille, Patricia</creator><creator>Schlenker, Evelyn H</creator><creator>Gerdes, A. Martin</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20051201</creationdate><title>Treatment of subclinical hypothyroidism reverses ischemia and prevents myocyte loss and progressive LV dysfunction in hamsters with dilated cardiomyopathy</title><author>Khalife, Wissam I ; Tang, Yi-Da ; Kuzman, James A ; Thomas, Tracy A ; Anderson, Brent E ; Said, Suleman ; Tille, Patricia ; Schlenker, Evelyn H ; Gerdes, A. Martin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c395t-9e7e32cdfb661e5f78bc108bba6d0b65c4f9f3b4c763fa88e3b24a9a602733f23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Animals</topic><topic>Cardiomyopathy, Dilated - complications</topic><topic>Cells, Cultured</topic><topic>Cricetinae</topic><topic>Disease Progression</topic><topic>Hypothyroidism - drug therapy</topic><topic>Hypothyroidism - etiology</topic><topic>Mesocricetus</topic><topic>Muscle Cells - drug effects</topic><topic>Muscle Cells - pathology</topic><topic>Thyroid Hormones - therapeutic use</topic><topic>Treatment Outcome</topic><topic>Ventricular Dysfunction, Left - etiology</topic><topic>Ventricular Dysfunction, Left - prevention &amp; control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Khalife, Wissam I</creatorcontrib><creatorcontrib>Tang, Yi-Da</creatorcontrib><creatorcontrib>Kuzman, James A</creatorcontrib><creatorcontrib>Thomas, Tracy A</creatorcontrib><creatorcontrib>Anderson, Brent E</creatorcontrib><creatorcontrib>Said, Suleman</creatorcontrib><creatorcontrib>Tille, Patricia</creatorcontrib><creatorcontrib>Schlenker, Evelyn H</creatorcontrib><creatorcontrib>Gerdes, A. Martin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of physiology. Heart and circulatory physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Khalife, Wissam I</au><au>Tang, Yi-Da</au><au>Kuzman, James A</au><au>Thomas, Tracy A</au><au>Anderson, Brent E</au><au>Said, Suleman</au><au>Tille, Patricia</au><au>Schlenker, Evelyn H</au><au>Gerdes, A. Martin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treatment of subclinical hypothyroidism reverses ischemia and prevents myocyte loss and progressive LV dysfunction in hamsters with dilated cardiomyopathy</atitle><jtitle>American journal of physiology. Heart and circulatory physiology</jtitle><addtitle>Am J Physiol Heart Circ Physiol</addtitle><date>2005-12-01</date><risdate>2005</risdate><volume>289</volume><issue>6</issue><spage>H2409</spage><epage>H2415</epage><pages>H2409-H2415</pages><issn>0363-6135</issn><eissn>1522-1539</eissn><abstract>1 Cardiovascular Research Institute-South Dakota Health Research Foundation, University of South Dakota School of Medicine and Sioux Valley Hospitals and Health Systems, and 2 Department of Internal Medicine, University of South Dakota School of Medicine, Sioux Falls, South Dakota Submitted 11 May 2005 ; accepted in final form 13 July 2005 Growing evidence suggests that thyroid dysfunction may contribute to progression of cardiac disease to heart failure. We investigated the effects of a therapeutic dose of thyroid hormones (TH) on cardiomyopathic (CM) hamsters from 4 to 6 mo of age. CM hamsters had subclinical hypothyroidism (normal thyroxine, elevated TSH). Left ventricular (LV) function was determined by echocardiography and hemodynamics. Whole tissue pathology and isolated myocyte size and number were assessed. TH treatment prevented the decline in heart rate and rate of LV pressure increase and improved LV ejection fraction. The percentage of fibrosis/necrosis in untreated 4-mo-old CM (4CM; 15.5 ± 2.2%) and 6-mo-old CM (6CM; 21.5 ± 2.4%) hamsters was pronounced and was reversed in treated CM (TCM; 11.9 ± 0.9%) hamsters. Total ventricular myocyte number was the same between 4- and 6-mo-old controls but was reduced by 30% in 4CM and 43% in 6CM hamsters. TH treatment completely prevented further loss of myocytes in TCM hamsters. Compared with age-matched controls, resting and maximum coronary blood flow was impaired in 4CM and 6CM hamsters. Blood flow was completely normalized by TH treatment. We conclude that TH treatment of CM hamsters with subclinical hypothyroidism normalized impaired coronary blood flow, which prevented the decline in LV function and loss of myocytes. thyroid hormones; remodeling; fibrosis; blood flow Address for reprint requests and other correspondence: A. M. Gerdes, Univ. of South Dakota School of Medicine, Cardiovascular Research Inst., 1100 E. 21st St., Sioux Falls, SD 57105 (e-mail: mgerdes{at}usd.edu )</abstract><cop>United States</cop><pmid>16024568</pmid><doi>10.1152/ajpheart.00483.2005</doi></addata></record>
fulltext fulltext
identifier ISSN: 0363-6135
ispartof American journal of physiology. Heart and circulatory physiology, 2005-12, Vol.289 (6), p.H2409-H2415
issn 0363-6135
1522-1539
language eng
recordid cdi_proquest_miscellaneous_68801568
source MEDLINE; American Physiological Society; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Animals
Cardiomyopathy, Dilated - complications
Cells, Cultured
Cricetinae
Disease Progression
Hypothyroidism - drug therapy
Hypothyroidism - etiology
Mesocricetus
Muscle Cells - drug effects
Muscle Cells - pathology
Thyroid Hormones - therapeutic use
Treatment Outcome
Ventricular Dysfunction, Left - etiology
Ventricular Dysfunction, Left - prevention & control
title Treatment of subclinical hypothyroidism reverses ischemia and prevents myocyte loss and progressive LV dysfunction in hamsters with dilated cardiomyopathy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-01T02%3A31%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_highw&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treatment%20of%20subclinical%20hypothyroidism%20reverses%20ischemia%20and%20prevents%20myocyte%20loss%20and%20progressive%20LV%20dysfunction%20in%20hamsters%20with%20dilated%20cardiomyopathy&rft.jtitle=American%20journal%20of%20physiology.%20Heart%20and%20circulatory%20physiology&rft.au=Khalife,%20Wissam%20I&rft.date=2005-12-01&rft.volume=289&rft.issue=6&rft.spage=H2409&rft.epage=H2415&rft.pages=H2409-H2415&rft.issn=0363-6135&rft.eissn=1522-1539&rft_id=info:doi/10.1152/ajpheart.00483.2005&rft_dat=%3Cproquest_highw%3E68801568%3C/proquest_highw%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68801568&rft_id=info:pmid/16024568&rfr_iscdi=true